Mefloquine, when it was used—I presume you're referring to the Somalia time frame—had been licensed and met the safety and effectiveness requirements of numerous regulatory bodies in many other countries, and in fact it was licensed shortly after the start of the Somalia deployment within Canada, meaning that it met the safety and effectiveness requirements of Canadian regulatory authorities.
On February 23rd, 2017. See this statement in context.